News
11h
MyChesCo on MSNMadrigal Licenses Oral GLP-1 Drug From CSPC, Targets Next-Gen MASH TherapyCONSHOHOCKEN, PA — Madrigal Pharmaceuticals (NASDAQ: MDGL) announced Monday it has secured exclusive global rights to develop ...
Court documents reveal that the drug dealer behind a multi-million dollar operation in Fayette County had a mole inside the sheriff’s department feeding him information and helping him stay one step ...
Advances in instruments and tools, as well as focused collaborations, improve accuracy and extend the range of applications.
A recent meta-analysis reveals no link between pathologic complete response and long-term survival in rectal cancer, challenging its use as a surrogate endpoint.
Parents of boys with Duchenne muscular dystrophy weigh in on drug innovation and medical regulation.
A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...
Groundbreaking heart valve device developed in Tulsa gives hope to those ineligible for traditional heart surgeries—discover ...
This week on "The Readout LOUD," STAT's biotech reporters parse what Vinay Prasad's ouster means for biotech and the FDA.
A collaborative study between Dana-Farber Cancer Institute and the Broad Institute found that 8.9% of children with glioma, ...
Such appeasement efforts proved insufficient to protect him from rival forces in the Republican Party, if not also in the ...
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...
Topical Ketamir-2 significantly reduced both acute and inflammatory pain behaviors in animals, demonstrating rapid onset, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results